BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mahmud SM, Sinnock H, Mostaço-Guidolin LC, Pabla G, Wierzbowski AK, Bozat-Emre S. Long-term trends in invasive pneumococcal disease in Manitoba, Canada. Hum Vaccin Immunother 2017;13:1884-91. [PMID: 28494193 DOI: 10.1080/21645515.2017.1320006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Wijayasri S, Hillier K, Lim GH, Harris TM, Wilson SE, Deeks SL. The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017. PLoS One 2019;14:e0226353. [PMID: 31834926 DOI: 10.1371/journal.pone.0226353] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
2 Dion SB, Major M, Gabriela Grajales A, Nepal RM, Cane A, Gessner B, Vojicic J, Suaya JA. Invasive pneumococcal disease in Canada 2010-2017: The role of current and next-generation higher-valent pneumococcal conjugate vaccines. Vaccine 2021;39:3007-17. [PMID: 33824041 DOI: 10.1016/j.vaccine.2021.02.069] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Larsen L, Bistrup C, Sørensen SS, Boesby L, Nguyen MTT, Johansen IS. The coverage of influenza and pneumococcal vaccination among kidney transplant recipients and waiting list patients: A cross-sectional survey in Denmark. Transpl Infect Dis 2021;23:e13537. [PMID: 33258216 DOI: 10.1111/tid.13537] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Holzer L, Hoffman T, Van Kessel DA, Rijkers GT. Pneumococcal vaccination in lung transplant patients. Expert Rev Vaccines 2020;19:227-34. [PMID: 32133883 DOI: 10.1080/14760584.2020.1738224] [Reference Citation Analysis]
5 Rezahosseini O, Møller DL, Sørensen SS, Perch M, Gustafsson F, Gelpi M, Knudsen J, Helleberg M, Rasmussen A, Nielsen SD, Harboe ZB. An Observational Prospective Cohort Study of Incidence and Outcome of Streptococcus pneumoniae and Hemophilus influenzae Infections in Adult Solid Organ Transplant Recipients. Microorganisms 2021;9:1371. [PMID: 34202542 DOI: 10.3390/microorganisms9071371] [Reference Citation Analysis]
6 Winje BA, Vestrheim DF, White RA, Steens A. The Risk of Invasive Pneumococcal Disease Differs between Risk Groups in Norway Following Widespread Use of the 13-Valent Pneumococcal Vaccine in Children. Microorganisms 2021;9:1774. [PMID: 34442853 DOI: 10.3390/microorganisms9081774] [Reference Citation Analysis]
7 Lewnard JA, Hanage WP. Making sense of differences in pneumococcal serotype replacement. The Lancet Infectious Diseases 2019;19:e213-20. [DOI: 10.1016/s1473-3099(18)30660-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
8 van Aalst M, Lötsch F, Spijker R, van der Meer JTM, Langendam MW, Goorhuis A, Grobusch MP, de Bree GJ. Incidence of invasive pneumococcal disease in immunocompromised patients: A systematic review and meta-analysis. Travel Med Infect Dis 2018;24:89-100. [PMID: 29860151 DOI: 10.1016/j.tmaid.2018.05.016] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 9.8] [Reference Citation Analysis]